Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study

Naltrexone can aid in reducing alcohol consumption, while acamprosate supports abstinence; however, not all patients with alcohol use disorder (AUD) benefit from these treatments. Here we present the first genome-wide association study of AUD treatment outcomes based on data from the COMBINE and PRE...

Descripción completa

Detalles Bibliográficos
Autores principales: Biernacka, Joanna M., Coombes, Brandon J., Batzler, Anthony, Ho, Ada Man-Choi, Geske, Jennifer R., Frank, Josef, Hodgkinson, Colin, Skime, Michelle, Colby, Colin, Zillich, Lea, Pozsonyiova, Sofia, Ho, Ming-Fen, Kiefer, Falk, Rietschel, Marcella, Weinshilboum, Richard, O’Malley, Stephanie S., Mann, Karl, Anton, Ray, Goldman, David, Karpyak, Victor M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505452/
https://www.ncbi.nlm.nih.gov/pubmed/34302059
http://dx.doi.org/10.1038/s41386-021-01097-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505452/
https://www.ncbi.nlm.nih.gov/pubmed/34302059
http://dx.doi.org/10.1038/s41386-021-01097-0

Ejemplares similares